BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12435675)

  • 1. Low frequencies of resistance among Staphylococcus and Enterococcus species to the bactericidal DNA polymerase inhibitor N(3)-hydroxybutyl 6-(3'-ethyl-4'-methylanilino) uracil.
    Butler MM; Skow DJ; Stephenson RO; Lyden PT; LaMarr WA; Foster KA
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3770-5. PubMed ID: 12435675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
    Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL
    Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria.
    Daly JS; Giehl TJ; Brown NC; Zhi C; Wright GE; Ellison RT
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2217-21. PubMed ID: 10898708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth.
    Zhi C; Long ZY; Gambino J; Xu WC; Brown NC; Barnes M; Butler M; LaMarr W; Wright GE
    J Med Chem; 2003 Jun; 46(13):2731-9. PubMed ID: 12801236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors.
    Zhi C; Long ZY; Manikowski A; Comstock J; Xu WC; Brown NC; Tarantino PM; Holm KA; Dix EJ; Wright GE; Barnes MH; Butler MM; Foster KA; LaMarr WA; Bachand B; Bethell R; Cadilhac C; Charron S; Lamothe S; Motorina I; Storer R
    J Med Chem; 2006 Feb; 49(4):1455-65. PubMed ID: 16480282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III: antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N3.
    Tarantino PM; Zhi C; Gambino JJ; Wright GE; Brown NC
    J Med Chem; 1999 Jun; 42(11):2035-40. PubMed ID: 10354411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activity of 3-substituted-6-(3-ethyl-4-methylanilino)uracils.
    Zhi C; Long ZY; Manikowski A; Brown NC; Tarantino PM; Holm K; Dix EJ; Wright GE; Foster KA; Butler MM; LaMarr WA; Skow DJ; Motorina I; Lamothe S; Storer R
    J Med Chem; 2005 Nov; 48(22):7063-74. PubMed ID: 16250666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New DNA polymerase IIIC inhibitors: 3-subtituted anilinouracils with potent antibacterial activity in vitro and in vivo.
    Svenstrup N; Ehlert K; Ladel C; Kuhl A; Häbich D
    ChemMedChem; 2008 Oct; 3(10):1604-15. PubMed ID: 18792034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria.
    Tarantino PM; Zhi C; Wright GE; Brown NC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1982-7. PubMed ID: 10428923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological characterization of novel inhibitors of the gram-positive DNA polymerase IIIC enzyme.
    Kuhl A; Svenstrup N; Ladel C; Otteneder M; Binas A; Schiffer G; Brands M; Lampe T; Ziegelbauer K; Rübsamen-Waigmann H; Haebich D; Ehlert K
    Antimicrob Agents Chemother; 2005 Mar; 49(3):987-95. PubMed ID: 15728893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
    Kosowska-Shick K; Clark C; Pankuch GA; McGhee P; Dewasse B; Beachel L; Appelbaum PC
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4217-24. PubMed ID: 19620338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antibiotic resistance, biofilm formation and conjugative transfer of Staphylococcus and Enterococcus isolates from International Space Station and Antarctic Research Station Concordia.
    Schiwon K; Arends K; Rogowski KM; Fürch S; Prescha K; Sakinc T; Van Houdt R; Werner G; Grohmann E
    Microb Ecol; 2013 Apr; 65(3):638-51. PubMed ID: 23411852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens.
    Jones RN; Moet GJ; Sader HS; Mendes RE; Castanheira M
    J Antimicrob Chemother; 2009 Apr; 63(4):716-20. PubMed ID: 19218276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved synthesis of antibacterial 3-substituted 6-anilinouracils.
    Svenstrup N; Kuhl A; Ehlert K; Häbich D
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3215-8. PubMed ID: 18468893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
    Hammer KA; Carson CF; Riley TV
    Int J Antimicrob Agents; 2008 Aug; 32(2):170-3. PubMed ID: 18571379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Borbone S; Lupo A; Mezzatesta ML; Campanile F; Santagati M; Stefani S
    Int J Antimicrob Agents; 2008 Mar; 31(3):209-15. PubMed ID: 17646087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-Steady-State Kinetic Characterization of an Antibiotic-Resistant Mutant of Staphylococcus aureus DNA Polymerase PolC.
    Nelson-Rigg R; Fagan SP; Jaremko WJ; Pata JD
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157122. PubMed ID: 37222615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections.
    Xu WC; Silverman MH; Yu XY; Wright G; Brown N
    Bioorg Med Chem; 2019 Aug; 27(15):3209-3217. PubMed ID: 31221610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.
    Tian Y; Li T; Zhu Y; Wang B; Zou X; Li M
    BMC Microbiol; 2014 Nov; 14():292. PubMed ID: 25420718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.